SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-009416
Filing Date
2018-04-27
Accepted
2018-04-27 06:06:22
Documents
95
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-10q_20180331.htm 10-Q 3177656
2 EX-10.1 bmrn-ex101_54.htm EX-10.1 38282
3 EX-31.1 bmrn-ex311_10.htm EX-31.1 16450
4 EX-31.2 bmrn-ex312_9.htm EX-31.2 16510
5 EX-32.1 bmrn-ex321_6.htm EX-32.1 5888
  Complete submission text file 0001564590-18-009416.txt   13751406

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20180331.xml EX-101.INS 4031192
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20180331.xsd EX-101.SCH 68339
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20180331_cal.xml EX-101.CAL 66086
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20180331_def.xml EX-101.DEF 272153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20180331_lab.xml EX-101.LAB 480002
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20180331_pre.xml EX-101.PRE 430881
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 18780860
SIC: 2834 Pharmaceutical Preparations